Author

J. M. Olson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

E. J. Girard· 2 shared A. J. Mhyre· 1 shared B. A. Badeau· 1 shared C. A. DeForest· 1 shared D. Kim· 1 shared E. S. Nealy· 1 shared F. J. Pakiam· 1 shared G. P. Sevilla· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

E. J. Girard

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effect

Z. R. Crook, G. P. Sevilla, P. Young, E. J. Girard, T.-D. Phi, M. Howard, J. Price, J. M. Olson, N. W. Nairn

CYpHER is a targeted protein degradation technology that uses pH-dependent release and the transferrin receptor to deliver drugs to endolysosomes, demonstrating potency and durability in vitro and in vivo.

Nature Communications · Oct 9, 2024Peer-reviewedBioengineering

Versatile Tissue-Injectable Hydrogels with Extended Hydrolytic Release of Bioactive Protein Therapeutics

E. S. Nealy, S. J. Reed, B. A. Badeau, S. M. Adelmund, J. A. Shadish, F. J. Pakiam, E. J. Girard, J. P. Price, A. J. Mhyre, V. Kalia, S. Sarkar, C. A. DeForest, J. M. Olson

This paper develops injectable hydrogels that enable controlled, extended release of protein therapeutics through hydrolysable linkers, demonstrating efficacy in a mouse melanoma model.

bioRxiv · Sep 1, 2023 · PreprintBioengineering

N-cadherin dynamically regulates pediatric glioma cell migration in complex environments

D. Kim, J. M. Olson, J. A. Cooper

This study shows N-cadherin dynamically regulates pediatric glioma cell migration by modulating cell-cell contacts and YAP1/TAZ signaling in different microenvironments.

bioRxiv · Apr 4, 2023Cancer Biology